The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Long Term Side Effects — What You Need to Know
Mounjaro (tirzepatide) is a prescription-only GIP and GLP-1 receptor agonist licensed in the UK for weight management. While clinical trials have shown positive weight loss results, understanding potential long-term side effects is important for anyone considering this medication. The MHRA currently monitors Mounjaro with additional surveillance (Black Triangle ▼ status), meaning new safety data is reviewed regularly. This guide explains what we know about long-term safety, common side effects that may persist, and what your GP should assess before prescribing.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Long Term Side Effects and Safety Data
Mounjaro has been in clinical use internationally since 2022, though long-term UK safety data is still accumulating. The SURMOUNT clinical trials tracked participants for up to 88 weeks, showing that most side effects like nausea and diarrhoea tend to improve over time as the body adjusts. However, some individuals experience persistent gastrointestinal effects — ongoing nausea, constipation, or reduced appetite even after several months of treatment.
Key long-term considerations:
- Muscle loss: gradual weight management can include muscle loss alongside fat loss; combining treatment with resistance exercise helps preserve lean mass
- Hair loss (alopecia): Some users report hair thinning during active weight loss — typically reversible once weight stabilises
- Gallbladder issues: gradual weight management increases gallstone risk; discuss with your GP if you have gallbladder history
- Vision changes: People with existing diabetic retinopathy may experience changes; regular eye screening is important
- Pancreatitis risk: Severe abdominal pain requires immediate medical attention as it may indicate pancreatitis
The MHRA's ongoing monitoring (Black Triangle status) means any emerging safety signals are actively tracked. Your GP should review your suitability regularly during treatment.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Prescribing and Long Term Monitoring
If prescribed Mounjaro through NHS tier 3 specialist weight management services, you will receive structured follow-up appointments to monitor side effects and weight loss progress. The NHS expects regular clinical review — typically every 4–12 weeks initially — to assess whether the medication remains appropriate and side effects are manageable.
Important points for NHS patients:
- You must disclose all existing medical conditions — particularly pancreatitis history, gallbladder problems, or diabetic retinopathy
- Oral contraceptive effectiveness may be reduced; use additional contraception for 4 weeks after starting and after each dose increase
- If side effects become intolerable, discuss alternatives with your specialist rather than stopping abruptly
- Long-term weight maintenance after stopping Mounjaro requires sustained lifestyle changes; weight typically returns without ongoing treatment and behaviour support
Use our free BMI calculator to track your baseline and progress, and our GLP-1 weight loss calculator to understand realistic expectations before starting treatment.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
What are the most common long-term side effects of Mounjaro?
Nausea, diarrhoea, constipation, and reduced appetite are most common in the short term (first 4–8 weeks) but often improve over time. Persistent effects vary by individual. Hair loss, gallstone risk, and muscle loss are longer-term considerations. Most users adjust within 12 weeks, though some experience ongoing mild gastrointestinal effects.
Is Mounjaro safe to use long term in the UK?
Mounjaro is licensed in the UK and monitored by the MHRA with additional surveillance (Black Triangle status). Clinical trial data from SURMOUNT studies supports safety up to 88 weeks. However, long-term data beyond two years is still accumulating. Your GP should regularly review whether the medication remains suitable for you during ongoing treatment.
Can Mounjaro cause permanent side effects?
Most Mounjaro side effects are temporary and reversible. Hair loss during weight loss is typically reversible once weight stabilises. However, gallstones resulting from gradual weight management may require surgical intervention. Pancreatitis is a serious risk that requires immediate medical attention. Always report persistent or severe symptoms to your GP immediately.
What happens to long-term weight loss after stopping Mounjaro?
Clinical evidence shows that most weight loss is regained if lifestyle changes are not maintained after stopping Mounjaro. The medication helps create weight loss; long-term success depends on sustained dietary changes and physical activity. Your GP or specialist can discuss transition plans to maintain your results.
How does NHS prescribing differ from private prescribing for Mounjaro long-term safety?
NHS patients receive structured specialist follow-up with regular monitoring appointments (typically every 4–12 weeks). Private patients should ensure their prescriber arranges comparable follow-up. Both routes require clinical assessment before starting. The key difference is accessibility to ongoing NHS specialist support — NHS patients have tier 3 services available, while private patients must arrange follow-up independently.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.